This clearance makes EchoGo ® Amyloidosis the first commercially available software-only medical device to facilitate detection of Cardiac Amyloidosis using echocardiography. Requiring a single ...

Amyloidosis is a rare condition defined by the abnormal production of proteins that bind together to form amyloid proteins.

20, 2024 /PRNewswire/ -- Ultromics' EchoGo ® Amyloidosis, clinical AI for echocardiography with the potential to revolutionize early detection of Cardiac Amyloidosis, has received US Food and ...

The new understanding of molecular events that drive the various forms of amyloidosis has generated treatment strategies that ...

EchoGo ® Amyloidosis is an AI-based software-only medical device, which aims to improve early detection of Cardiac Amyloidosis, an underdiagnosed cause of heart failure. EchoGo ® Amyloidosis sits on ...

In the developed world, cardiologists predominantly encounter three main types of amyloidosis that affect the heart; light chain (AL) amyloidosis, senile systemic amyloidosis (SSA), and familial ...

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the ...